Medically reviewed for accuracy July 26, 2026. Genetic tests may provide information about inherited variants or disease risk, but they do not generally diagnose Alzheimer’s disease, dementia, Parkinson’s disease, epilepsy, or ALS on their own. This category review explains the benefits, limitations, privacy questions, and follow-up steps older adults should consider before using a clinical or direct-to-consumer DNA test.
Quick answer: A genetic result can sometimes help a specialist investigate a strong family history or an unusually early onset of symptoms. For most older adults, however, a risk variant is not a diagnosis and a negative result does not rule out disease. Discuss testing with a licensed clinician or genetic counselor before making medical decisions.
What neurological genetic testing can show
A test analyzes selected parts of a person’s DNA. Depending on why the test was ordered, a laboratory may look for a specific inherited variant, a group of genes associated with a condition, or a risk marker. The meaning of the result depends on the exact gene, the quality and scope of the test, the person’s symptoms, and family history.
For Alzheimer’s disease, the National Institute on Aging explains that genetic tests are not routinely used to diagnose or predict who will develop Alzheimer’s or a related dementia. APOE results, for example, cannot fully predict who will or will not develop the disease. A specialist may consider testing in selected cases, such as early symptoms combined with a strong family history.
What a result cannot promise
- A risk marker does not prove that a person has or will develop a neurological disorder.
- A negative result does not rule out every genetic or non-genetic cause.
- A consumer test should not be used to start, stop, or change medication.
- No DNA test can guarantee prevention, delayed progression, or peace of mind.
- Results for one person can have emotional and privacy implications for relatives.
Clinical testing versus direct-to-consumer testing
Clinical testing is usually selected by a clinician based on symptoms and family history, performed by an appropriate laboratory, and interpreted with medical context. Direct-to-consumer tests are purchased without the same clinical pathway. The FDA notes that some consumer tests are reviewed while others are not, and that the agency has not authorized direct-to-consumer pharmacogenetic tests to predict response or adverse reaction to a specific medicine.
Before purchasing, ask for the test’s exact name, laboratory, regulatory status, genes analyzed, limitations, privacy policy, data-retention rules, deletion process, and whether genetic counseling is included. Be cautious with broad promises such as “early diagnosis,” “personalized prevention,” or guaranteed medication matching.
Questions to ask before testing
- What decision will this result help make? Testing is more useful when there is a clear clinical question.
- Who will interpret it? Ask whether a neurologist, genetics professional, or licensed clinician will review the result in context.
- What are the possible uncertain findings? Some variants have unclear significance and may not lead to an answer.
- How is the sample and data protected? Ask about storage, sharing, research use, third-party access, and deletion.
- What will it cost? Coverage differs by test, reason, ordering provider, laboratory, and insurance plan. Get a written estimate.
What to do if you already have a result
Do not change medication or treatment based only on a consumer report. Save the complete laboratory report, list the symptoms and family history that prompted testing, and schedule a conversation with the appropriate clinician or genetic counselor. Ask what the result means, what it does not mean, whether confirmatory testing is needed, and what ordinary clinical evaluation is still appropriate.
Support for seniors and families in Los Angeles
All Seniors Foundation provides educational navigation and may help older adults and families in Los Angeles County connect with appropriate community or care resources. We do not diagnose neurological conditions, sell genetic tests, interpret genetic results, or guarantee coverage. For help locating support, call (818) 581-4101 or use our contact page.
Frequently asked questions
Can a DNA test diagnose Alzheimer’s disease?
Not by itself. The National Institute on Aging states that genetic testing is not routinely used to diagnose or predict Alzheimer’s disease. Diagnosis requires clinical evaluation and may involve cognitive testing, medical history, imaging, laboratory work, or biomarkers.
Is APOE testing conclusive?
No. APOE variants can affect risk, but they cannot fully predict who will or will not develop Alzheimer’s disease.
Should family members be tested?
That is an individual medical and personal decision. A genetic counselor can help a family understand potential value, limitations, emotional effects, and privacy considerations before anyone tests.
Does Medicare cover neurological genetic testing?
Coverage depends on the clinical reason, test, ordering provider, laboratory, and current Medicare rules. Confirm coverage with Medicare or the plan before testing.
Authoritative resources
- National Institute on Aging: Alzheimer’s Disease Genetics
- FDA: Direct-to-Consumer Tests
- FDA: Pharmacogenomic Biomarkers in Drug Labeling
This page is educational and is not a diagnosis, treatment recommendation, or substitute for advice from a licensed clinician. For a medical emergency, call 911.
